Moreover, our in vivo experiment results confirmed that SFN treatment substantially decreased the adipocyte size and body weight gain, and further prevented HFD-induced obesity through the browning of adipocytes via mitochondrial biogenesis and the activation of Ucp1 and Pgc1-α. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.